Description
Book SynopsisTable of Contents1. Liver Cancer Risk-Predictive Molecular Biomarkers Specific to Clinico-epidemiological Contexts Yujin Hoshida, Naoto Kubota, Naoto Fujiwara 2. Inflammatory Pathways and Hepatobiliary Cancer Risk Mechanisms and Prevention Mario Strazzabosco and Massimiliamo Cadamuro 3. Causes and Functional Intricacies of Inter- and Intratumor Heterogeneity in Primary Liver Cancers Xin Wei Wang and Subreen Khatib 4. Implication of Genetic Heterogeneity in Hepatocellular Cancer Renumathy Dhanasekaran 5. Understanding the Genetic Basis for Cholangiocarcinoma Lewis R. Roberts and Mikayla A. Schmidt 6. Novel Insights into Molecular and Immune Subtypes of Intrahepatic Cholangiocarcinoma Daniela Sia and Emily Bramel 7. Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma Progression and Therapeutic Resistance Silvia Affo, Aashreya Ravichandra, Sonakshi Bhattacharjee 8. Mechanisms and Clinical Significance of TGF-ß in Hepatobiliary Cancer Progression Lopa Mishra and Zobia Zaidi 9. Matricellular proteins in intrahepatic cholangiocarcinoma Alphonse Eugene Sirica 10. Yap Activation and Hippo Pathway Signaling in the Pathogenesis and Prognosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Satdarshan (Paul) Singh Monga, Sungjin Ko, Yuhua Xue, George K. Michalopoulos, 11. Patient-derived Functional Organoids as a Personalized Approach for Drug Screening Against Hepatobiliary Cancers Florin M. Selaru and Ling Li 12. Molecular Therapeutic Targets for Cholangiocarcinoma: Present Challenges and Future Possibilities Jesper B. Andersen, Colm J. O’Rourke, Dan Høgdall 13. Immunotherapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Current and Developing Strategies Bruno Sangro and Josepmaria Argemi 14. Immunotherapy for Hepatobiliary Cancers: Emerging Targets and Translational Advances Mitchell Ho, Dan Li, Shaoli Lin, Jessica Hong
